Journal
JOURNAL OF ORGANIC CHEMISTRY
Volume 69, Issue 21, Pages 7051-7057Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jo049094b
Keywords
-
Categories
Funding
- NIAID NIH HHS [R01 AI52061] Funding Source: Medline
Ask authors/readers for more resources
The nucleoside boranophosphates, having one of the nonbridging phosphate oxygens substituted with a borane (BH3) group, have shown potential therapeutical applications as aptamers, antisense agents, and antiviral prodrugs. An oxathiaphospholane approach, which does not require exocyclic amine protection of the nucleobase, has been successfully developed to efficiently synthesize 5'-P-alpha-boranodiphosphates of 2'-deoxythymidine, adenosine, guanosine, and uridine. The approach involves a key intermediate, the borane complex of nucleoside 5'-O-1,3,2-oxathiaphospholane 16, that undergoes a ring-opening reaction catalyzed by 1,4-diazabicyclo[5.4.0]-undec-7-ene to form the protected nucleoside 5'-P-alpha-boranodiphosphate 18. Treatment of 18 with ammonium hydroxide yielded diastereoisomeric mixtures of nucleoside 5'-P-alpha-boranodiphosphates 5. This oxathiaphospholane approach ensures the availability of nucleoside 5'-P-alpha-boranodiphosphate analogues needed for antiviral drug research.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available